WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention use of mRNA tests for human papillomavirus (HPV)
This current guideline delivers the initial output of the second phase of the guideline update: recommendations for the use of HPV mRNA (messenger ribonucleic acid) tests for screening to detect cervical pre-cancer and prevent cervical cancer
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Geneva, Switzerland
World Health Organization
2021, [2021]
|
| Edition: | Second edition |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | This current guideline delivers the initial output of the second phase of the guideline update: recommendations for the use of HPV mRNA (messenger ribonucleic acid) tests for screening to detect cervical pre-cancer and prevent cervical cancer |
|---|---|
| Physical Description: | 1 PDF file (xvi, 51 pages) illustrations |
| ISBN: | 9789240040434 9789240040441 |